Naltrexone And Bupropion
A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects
Orexigen Therapeutics, Inc · Phase 3 · Completed · Enrollment 1742
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| NB16 | 155 participants | 36 participants | 31 participants | n/r | n/r |
| NB32 | 171 participants | 56 participants | 26 participants | n/r | n/r |
| Placebo | 30 participants | 14 participants | 28 participants | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.